Evidence map›Paper›PMID 42631199›Full record

SynthesisWideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques2026

Prevalence and risk factors for postoperative incisional hernia after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta‑analysis and systematic review.

Qing Zeng, Xianping Yuan, Xing Wei

Abstract readSystematic Review
In one paragraph

Synthesis in Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qing ZengEmergency Department Ganzhou People's Hospital China.
Xianping YuanDepartment of Obstetrics, Ganzhou Maternal and Child Health Hospital, Ganzhou, Jiangxi Province, China.
Xing WeiDepartment of Gynecology, Ganzhou Maternal and Child Health Hospital, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The prevalence and risk factors for postoperative incisional hernia (IH) following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) remain uncertain, with published studies reporting highly variable outcomes. Aim: This systematic review and meta-analysis aimed to estimate the pooled prevalence of IH after CRS-HIPEC and risk factors associated with it. Materials and methods: A comprehensive search of the PubMed, Embase, and Cochrane Library databases was conducted to identify relevant observational studies. A total of 12 studies reporting IH after CRS-HIPEC were included. Study quality was assessed using the Newcastle-Ottawa Scale, and random-effects models were applied to calculate pooled prevalence and risk factors for postoperative IH following CRS-HIPEC. Subgroup, sensitivity, and publication bias analyses were performed to evaluate robustness of the findings. Results: A total of 12 studies comprising 2170 patients were qualified for this review. The estimated average pooled prevalence of IH after CRS-HIPEC was 13% (95% CI, 9-16), with individual study estimates ranging from 6.9% to 26.9%, and substantial heterogeneity ( Conclusions: IH is a notable and clinically relevant long-term complication following CRS-HIPEC. The risk of IH is driven primarily by patient age, obesity, perioperative chemotherapy exposure, gastrointestinal reconstruction, and postoperative complications.

Indexed as

cytoreductive surgeryhyperthermic intraperitoneal chemotherapyincisional herniameta­‑analysis

Identifiers

PMID42631199
PMCPMC13496023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.